The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer

This publication has 20 references indexed in Scilit:

• Dose‐surface histograms as treatment planning tool for prostate conformal therapy
  Medical Physics, 1995
• On Neoadjuvant Hormonal Downsizing of Localized Carcinoma of the Prostate: Effects on the Volume of Normal Tissue Irradiation
  Cancer Investigation, 1995
• Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate
  Urology, 1993
• Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Preoperative Androgen Deprivation Therapy: Artificial Lowering of Serum Prostate Specific Antigen without Downstaging the Tumor
  Journal of Urology, 1993
• Conformal radiation in prostate cancer: Reduced morbidity with hope of increased local control
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy
  Radiotherapy and Oncology, 1992
• Phase II Radiation Therapy Oncology Group Study of Hormonal Cytoreduction with Flutamide and Zoladex in Locally Advanced Carcinoma of the Prostate Treated with Definitive Radiotherapy
  American Journal of Clinical Oncology, 1990
• Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate— analysis of rtog study 75-06
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1984